Overview

A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea

Status:
Completed
Trial end date:
2016-05-30
Target enrollment:
Participant gender:
Summary
This is a phaseIV, multicenter, open-label,single arm study which will be performed to evaluate efficacy and safety of Ceftriaxone sodium and Sulbactam Sodium for injection for the treatment of uncomplicated urogenital infection caused by Neisseria gonorrhoeae in adolescent and adult subjects.
Phase:
Phase 4
Details
Lead Sponsor:
Xiangbei Welman Pharmaceutical Co., Ltd
Treatments:
Ceftriaxone
Sulbactam